AHA again urged the Food and Drug Administration today to allow health system pharmacies to distribute compounded products to other system facilities located more than one mile away. “The AHA is concerned that the one-mile radius limitation [included in draft guidance last year] is not workable for many hospitals and health systems that have centralized their sterile compounding activities in a single location and distribute compounded products to their other system facilities located more than one mile away,” wrote Ashley Thompson, AHA senior vice president for public policy analysis and development, responding to the agency’s request for information on regulatory flexibilities and efficiencies. Instead of the one-mile limit, AHA recommends that the agency allow hospitals and health systems to use the beyond-use date timeframes contained in United States Pharmacopoeia Chapters 797 and 800. AHA also recommended greater FDA oversight of medical device cybersecurity. “We recommend that the FDA proactively set clear measurable expectations for manufacturers before incidents and play a more active role during cybersecurity attacks.”

Related News Articles

Headline
The Health and Public Health Sector Coordinating Council, a public-private partnership, yesterday released a crisis response guide to help health care…
Headline
The Healthcare and Public Health Sector Coordinating Council, a public-private partnership developed to mitigate threats to the nation’s health care sector,…
Headline
China and its proxies have been observed attempting to identify and illicitly obtain valuable intellectual property and public health data related to vaccines…
Headline
The Department of Homeland Security and the Cybersecurity and Infrastructure Security Agency have updated their telework guidance to include new guidance on…
Headline
Cyber actors have launched phishing campaigns against first responders, initiated denial-of-service assaults against government agencies and threatened medical…
Headline
The FBI warned today of specific COVID-19-themed email phishing campaigns targeting U.S.-based medical providers. The campaigns leverage email subject lines…